文献速递类风湿关节炎

微小RNA干扰类风湿关节炎滑膜成纤维细胞的DNA甲基化

MicroRNAs interfere with DNA methylation in rheumatoid arthritis synovial fibroblasts.
PubMed 文献 · RMD Open · 2016-10-14

该研究探讨了甲基供体(L-甲硫氨酸或甜菜碱)对类风湿关节炎滑膜成纤维细胞(RASF)DNA甲基化的影响及微小RNA(miR)的干扰作用。结果显示L-甲硫氨酸增加DNA甲基化比甜菜碱更有效,甜菜碱通过上调靶向DNMT3A的miR29限制再甲基化,但仍抑制多种转录因子、减少MMP-1释放和细胞迁移。结论提示miR谱改变(尤其miR29上调)可能限制甜菜碱作为DNA再甲基化剂的效率。

要点

  • L-甲硫氨酸增加RASF DNA甲基化比甜菜碱更有效。
  • 甜菜碱上调miR29靶向DNMT3A,限制再甲基化过程。
  • 甜菜碱抑制转录因子、减少MMP-1释放和细胞迁移。

核心结论

  • 细胞miR谱改变,特别是靶向DNMT3A的miR29上调,可能限制甜菜碱作为DNA再甲基化剂的效率。
  • 甜菜碱对RASF活化表型有多重有益效应,其对DNMT3A的作用可能至少部分为间接效应。
  • 甜菜碱的临床试验可能是有前景的。

研究设计与样本

  • RASF分别用L-甲硫氨酸或甜菜碱处理。
  • 用实时PCR检测DNMTs和miRs转录本,并进行转录PCR阵列。
  • 测定同型半胱氨酸、MMP-1水平和整体DNA甲基化。
  • 用脂质体转染特定pre-miRs和anti-miRs(如miR29和let7f)。

主要发现

  • L-甲硫氨酸增加DNA甲基化比甜菜碱更有效。
  • 甜菜碱处理的RASF中DNMT3A mRNA表达降低。
  • 甜菜碱增加RASF中靶向DNMT3A的miR29表达,从而限制再甲基化过程。
  • 甜菜碱抑制多种转录因子表达,减少MMP-1释放、同型半胱氨酸生物合成和细胞迁移。

临床怎么用

  • 甜菜碱作为DNA再甲基化剂时,miR29上调可能限制其效率。
  • 甜菜碱对RASF活化表型有多重有益效应,支持其临床试验探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The DNA of rheumatoid arthritis synovial fibroblasts (RASF) is globally hypomethylated; this contributes to an aggressive behaviour. In an attempt to remethylate these cells, we supplemented with methyl donors. We investigated the possible interference of microRNAs (miRs). MATERIAL AND METHODS: RASF were treated with L-methionine or betaine. Transcripts of de novo methyltransferases (DNMTs) and miRs were measured by real-time PCR, and a transcription PCR array was performed. Levels of homocysteine, matrix metalloproteinase-1 (MMP-1) and global DNA methylation were determined. Transfection with lipofectamine was performed with specific pre-miRs and anti-miRs, such as miR29 and let7f. RESULTS: L-methionine was more efficient to increase DNA methylation than betaine. This was associated with a reduced expression of DNMT3A mRNA in betaine-treated RASF. Betaine increases the expression of miR29 in RASF which targets DNMT3A, thereby limiting the remethylation process. Nevertheless, betaine inhibited the expression of multiple transcription factors, decreased the release of MMP-1, biosynthesis of homocysteine and cell migration. CONCLUSION: Alterations in cellular miRs profiles, in particular the upregulation of miR29, which targets DNMT3A, may limit the efficiency of betaine if it is used as DNA remethylating agent. However, L-methionine also has similar impact on miR29 expression. On the other hand, betaine has multiple other beneficial effects on the activated phenotype of RASF; it is not excluded that the effect of betaine on DNMT3A is, at least in part, indirect. Clinical trials with betaine could be promising.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Gaur N, Karouzakis E, Glück S, et al. MicroRNAs interfere with DNA methylation in rheumatoid arthritis synovial fibroblasts. RMD Open. 2016. PMID: 27843576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。